BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hoffmann D, Bayer W, Wildner O. In situ tumor vaccination with adenovirus vectors encoding measles virus fusogenic membrane proteins and cytokines. World J Gastroenterol 2007; 13(22): 3063-3070 [PMID: 17589921 DOI: 10.3748/wjg.v13.i22.3063]
URL: https://www.wjgnet.com/1007-9327/full/v13/i22/3063.htm
Number Citing Articles
1
C M Wong, L A Nash, J Del Papa, K L Poulin, T Falls, J C Bell, R J Parks. Expression of the fusogenic p14 FAST protein from a replication-defective adenovirus vector does not provide a therapeutic benefit in an immunocompetent mouse model of cancerCancer Gene Therapy 2016; 23(10): 355 doi: 10.1038/cgt.2016.41
2
Qi‐Xiang Li, Guohong Liu, Flossie Wong‐Staal. Oncolytic virotherapy as a personalized cancer vaccineInternational Journal of Cancer 2008; 123(3): 493 doi: 10.1002/ijc.23692
3
Joshua Del Papa, Robin Parks. Adenoviral Vectors Armed with Cell Fusion-Inducing Proteins as Anti-Cancer AgentsViruses 2017; 9(1): 13 doi: 10.3390/v9010013
4
Joshua Del Papa, Ryan G. Clarkin, Robin J. Parks. Use of cell fusion proteins to enhance adenoviral vector efficacy as an anti-cancer therapeuticCancer Gene Therapy 2021; 28(7-8): 745 doi: 10.1038/s41417-020-0192-9
5
Dennis Hoffmann, Wibke Bayer, Albert Heim, Anja Potthoff, Dirk M. Nettelbeck, Oliver Wildner. Evaluation of Twenty-One Human Adenovirus Types and One Infectivity-Enhanced Adenovirus for the Treatment of Malignant MelanomaJournal of Investigative Dermatology 2008; 128(4): 988 doi: 10.1038/sj.jid.5701131
6
Sai V. Vemula, Omar Amen, Jacqueline M. Katz, Ruben Donis, Suryaprakash Sambhara, Suresh K. Mittal. Beta-defensin 2 enhances immunogenicity and protection of an adenovirus-based H5N1 influenza vaccine at an early timeVirus Research 2013; 178(2): 398 doi: 10.1016/j.virusres.2013.09.013
7
Dennis Hoffmann, Thomas Grunwald, Wibke Bayer, Oliver Wildner. Immune-mediated anti-neoplastic effect of intratumoral RSV envelope glycoprotein expression is related to apoptotic death of tumor cells but not to the size of syncytiaWorld Journal of Gastroenterology 2008; 14(12): 1842-1850 doi: 10.3748/wjg.14.1842
8
Marcio O Lasaro, Hildegund CJ Ertl. New Insights on Adenovirus as Vaccine VectorsMolecular Therapy 2009; 17(8): 1333 doi: 10.1038/mt.2009.130
9
Yumei Luo, Detu Zhu, Dang Hoang Lam, Juan Huang, Yi Tang, Xitu Luo, Shu Wang. A Double-Switch Cell Fusion-Inducible Transgene Expression System for Neural Stem Cell-Based Antiglioma Gene TherapyStem Cells International 2015; 2015: 1 doi: 10.1155/2015/649080
10
MASATO OKIGAMI, KOJI TANAKA, YASUHIRO INOUE, SUSUMU SAIGUSA, YOSHINAGA OKUGAWA, YUJI TOIYAMA, YASUHIKO MOHRI, MASATO KUSUNOKI. Intravital imaging of the effects of 5-fluorouracil on the murine liver microenvironment using 2-photon laser scanning microscopyOncology Letters 2016; 11(4): 2433 doi: 10.3892/ol.2016.4258
11
Nasser Hashemi Goradel, Babak Negahdari, Sajjad Ghorghanlu, Samira Jahangiri, Arash Arashkia. Strategies for enhancing intratumoral spread of oncolytic adenovirusesPharmacology & Therapeutics 2020; 213: 107586 doi: 10.1016/j.pharmthera.2020.107586
12
Olga V Matveeva, Zong S Guo, Svetlana A Shabalina, Peter M Chumakov. Oncolysis by paramyxoviruses: multiple mechanisms contribute to therapeutic efficiencyMolecular Therapy - Oncolytics 2015; 2: 15011 doi: 10.1038/mto.2015.11
13
Jason S. Buhrman, Tooba A. Cheema, Giulia Fulci. Emerging Cancer Therapy2010; : 141 doi: 10.1002/9780470626528.ch7